Corline Biomedical (CLBIO.ST) Stock Price
Corline Biomedical Price
Over the last 13 years Corline Biomedical grew revenue by 1.9% annually, reaching 7.65 M SEK. For Corline Biomedical, the net margin of -192.3% is down versus -97.9% a few years ago.
Corline Biomedical stock price
Corline Biomedical business model & stock analysis
Frequently asked questions about Corline Biomedical
Converted at the current exchange rate, the Corline Biomedical share trades at 1.25 EUR (14.15 SEK).
The Corline Biomedical share (CLBIO.ST) is listed on 2 stock exchanges, including: Stockholm (CLBIO.ST).
No history available for Corline Biomedical.
The expected revenue of Corline Biomedical is 30.10 M SEK. This figure is based on current financial data and reflects the company's business performance.
The expected profit of Corline Biomedical is 17.93 M SEK. The net profit reflects the company's profitability after deducting all expenses.
The price-to-earnings ratio (P/E) of Corline Biomedical is currently 20.10. The P/E ratio compares the current share price to the earnings per share and helps investors assess the valuation of the Corline Biomedical stock.
The price-to-sales ratio (P/S) of Corline Biomedical is currently 11.97. The P/S ratio compares the market capitalization to the annual revenue and serves as a valuation metric for the Corline Biomedical stock.
The Eulerpool Quality Score for Corline Biomedical is 2/10.
The ISIN of Corline Biomedical is SE0006887451. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.
The ticker of Corline Biomedical is CLBIO.ST. The ticker symbol is used to trade Corline Biomedical shares on the stock exchange.
Corline Biomedical paid dividends every year for the past 0 years.
Corline Biomedical is assigned to the 'Health' sector.
The dividends of Corline Biomedical are distributed in SEK.
Corline Biomedical stock
Corline Biomedical Peer Group
Corline Biomedical Ticker
Corline Biomedical FIGI
All fundamentals and in-depth analysis of Corline Biomedical
Our stock analysis for Corline Biomedical stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Corline Biomedical. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.